ArticleInternal medicine (Tokyo, Japan)2025

Efficacy and Safety of First-line Pembrolizumab Plus Platinum and Pemetrexed in Elderly Patients with Non-squamous Non-small-cell Lung Cancer.

Satoshi Wasamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.